ROLE OF GLP-1 AGONISTS IN THE TREATMENT OF OBESITY-RELATED GASTROINTESTINAL DISORDERS. RMSR [Internet]. 2025 Apr. 15 [cited 2026 Oct. 12];3(4):1205-14. Available from: https://medicalsciencereview.com/index.php/Journal/article/view/1966